Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

altRX vs BiltRx

By GLP-1 ScorecardUpdated

altRXFactor scores not reassessed.
Site position #223

Lower score

BiltRxFactor scores not reassessed.
Site position #59

Higher score

Score comparison

BiltRx has the higher recorded score — 75.3/100 to 66/100.

BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.

Before you choose

Before comparing the headline prices, the altRX review and the BiltRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, altRX vs Cielo and AM Rx vs BiltRx compare each of them with another graded program, and the list of alternatives to altRX ranks the programs closest to altRX on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueBiltRx +17
74
91
Dose & formulationBiltRx +8
77
85
Clinical oversightBiltRx +19
55
74
Labs & monitoringaltRX +1
53
52
FulfillmentaltRX +2
73
71
Contract termsEven
55
55
altRX · top barBiltRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricaltRXBiltRx
WeighScore66/10075.3/100
GradeCC
Site position#223#59
Semaglutide$89/mo (advertised, compounded; selected term and charge unverified)$82/mo advertised medication starting price; confirm care and shipping charges
Tirzepatide$149/mo (advertised, compounded; selected term and charge unverified)$130/mo advertised medication starting price; confirm care and shipping charges
CoverageCoverage not publishedAll 50 states advertised
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
altRX

Site position #223 · C

Factor scores not reassessed.

FDAWarning letter issued to Trinity HealthCare Supply, LLC dba altRx in June 2026. See the FDA warning-letter database.

Strengths

  • Publishes separate compounded treatment pages
  • Lists Zepbound, Wegovy and Ozempic on the public menu
  • Publishes a cancellation cutoff

What to consider

  • The displayed rates do not establish the selected charge
  • Bundled plans are generally nonrefundable
  • Cancellation requires at least 72 hours’ notice before renewal
BiltRx

Site position #59 · C

Factor scores not reassessed.

Strengths

  • Publishes 12-week package totals
  • Explains the consultation charge if treatment is declined

What to consider

  • Confirm whether consultation and shipping are included in the selected plan
  • Renewal cancellation does not refund an approved order

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard